Skip to content
drillr.ai
Sign up

FEMY

FEMASYS INC

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$2.59
+1.57%
Ask drillr

  • Sep 15, 2026, 13:00 UTC

    Femasys Inc. announced that Minnesota Women's Care will implement FemVue for fertility diagnostic evaluation and FemaSeed Complete for in-office first-line fertility treatment across its four OB/GYN practice locations.

    Source:

  • Sep 9, 2026, 13:00 UTC

    Femasys Inc. announced a partnership with CapexMD to expand patient access to its FemaSeed fertility portfolio through dedicated financing solutions.

    Source:

  • Aug 26, 2026, 13:00 UTC

    Femasys Inc. announced a partnership with UNC Health to introduce its fertility products FemVue, SpermVue, and FemaSeed Complete across UNC Health OB/GYN practice locations.

    Source:

  • Aug 19, 2026, 17:36 UTC

    The U.S. Food and Drug Administration (FDA) authorized the modular premarket approval application pathway for Femasys's FemBloc non-surgical permanent birth control technology on Wednesday.

    Source:

  • Aug 14, 2026, 20:05 UTC

    Femasys Inc. announced its financial results for the quarter ended June 30, 2026.

    Source:

  • Aug 7, 2026, 13:25 UTC

    Femasys Inc. announced a $30 million private placement of securities with accredited investors, led by Nantahala Capital, with potential additional proceeds of up to $90 million from warrant exercises, expected to close around August 10, 2026.

    Source:

  • Jun 24, 2026, 13:00 UTC

    Femasys Inc. received formal notice from Nasdaq confirming it has regained compliance with the minimum bid price listing requirement.

    Source: